EUCTR2011-001821-26-IT进行中（未招募）不适用
Aerosol Tobramycin 300 mg single dose in adult patient with cystic fibrosis: pilot study of antimicrobial activity
FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO0 个研究点开始时间: 2012年3月20日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Out patient, both sexes, age 18-45. - diagnosys of cystic fibrosis - FEV1 >50% predicted - availability of sputum sample for microbiology - chest X ray negative for pneumonia and active tubercolosis - signed informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Hypersensibility or allergy to the study drug -use of systemic steroids (less than 2 weeks from the screening) - Pregnancy or lactation - partecipation in clinical trial with sperimental drug 4 weeks before enrollment
研究者
相似试验
进行中（未招募）
1 期
A study comparing Tobramycin Inhalation Powder (TIP) administered once daily continuously versus TIP administered BID in 28 day on / 28 day off cycles for the treatment of pulmonary Pseudomonas aeruginosa in patients with cystic fibrosisMedDRA version: 20.0Level: PTClassification code 10011762Term: Cystic fibrosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 20.0Level: LLTClassification code 10021860Term: Infection Pseudomonas aeruginosaSystem Organ Class: 100000004862Cystic FibrosisEUCTR2016-004318-82-Outside-EU/EEAovartis Pharmaceuticals Corporation200
已完成
3 期
ong-term inhaled nebulized tobramycin in patients with non-cystic fibrosis bronchiectasis. A randomized placebo controlled trial. The BATTLE study Bronchiectasis And Tobramycin SoluTion InhaLation ThErapy.bronchiectasis10006436NL-OMON47248Medisch Centrum Alkmaar58
招募中
3 期
Addition of Tobramycin inhalation antibiotic treatment to standard IV antibiotic treatment for ventilator-associated pneumoniaNL-OMON40796Erasmus MC, Universitair Medisch Centrum Rotterdam42
进行中（未招募）
不适用
asale Inhalation von Tobramycin mit dem Pari Sinus-Vernebler bei Patienten mit Mukoviszidose und Pseudomonasnachweis im Nasen-Nasennebenhöhlenbereich.Nasal inhalation of tobramycin by the Pari Sinus nebulizer in patients with cystic fibrosis and pseudomonas aeruginosa colonization in the upper airways. - tobra nasal CF pilotsubjects with cystic fibrosis and pseudomonas aeruginosa colonization in the upper airwaysEUCTR2008-000164-17-DEniversity of Jena14
尚未招募
不适用
Inhalation of tobramycin for the patients with persistent respiratory infection by Psudomonas aeruginosaPersistent respiratory infection by Pseudomonas aeruginosaJPRN-UMIN000002893Kumamoto university hospital5